Autopsy report · NCT04260256
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
Cause of deathFunding or business
“lack of funding”
Life of this trial
- Registered 2 years 1 month before it started.
- Ran for about 4 years before it stopped.
- 9 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- CellSight Technologies, Inc.
- Sponsor type
- Industry
- Conditions
- Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit
- Interventions
- [18F]F-AraG
- Participants
- 9
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.